Literature DB >> 27694500

Matching inside and outside the HLA molecule in allogeneic hematopoietic stem cell transplantation.

J Alejandro Madrigal1, Linda D Barber2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27694500      PMCID： PMC5046643          DOI： 10.3324/haematol.2016.150995

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Identifiying human MHC supertypes using bioinformatic methods.

Authors:  Irini A Doytchinova; Pingping Guan; Darren R Flower
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

2.  Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific.

Authors:  Avital L Amir; Dirk M van der Steen; Renate S Hagedoorn; Michel G D Kester; Cornelis A M van Bergen; Jan W Drijfhout; Arnoud H de Ru; J H Frederik Falkenburg; Peter A van Veelen; Mirjam H M Heemskerk
Journal:  Blood       Date:  2011-10-04       Impact factor: 22.113

3.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

4.  HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.

Authors:  Judith A Wade; Carolyn Katovich Hurley; Steven K Takemoto; John Thompson; Stella M Davies; Thomas C Fuller; Glenn Rodey; Dennis L Confer; Harriet Noreen; Michael Haagenson; Fangyu Kan; John Klein; Mary Eapen; Stephen Spellman; Craig Kollman
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 5.  National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.

Authors:  Robert A Bray; Carolyn K Hurley; Naynesh R Kamani; Ann Woolfrey; Carlheinz Müller; Stephen Spellman; Michelle Setterholm; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

6.  Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.

Authors:  L Luznik; S Jalla; L W Engstrom; R Iannone; E J Fuchs
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

7.  Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.

Authors:  Stephen Spellman; John Klein; Michael Haagenson; Medhat Askar; Lee Ann Baxter-Lowe; Jun He; Susan Hsu; Rainer Blasczyk; Carolyn Hurley
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

8.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

Review 9.  Umbilical cord blood transplantation: the first 25 years and beyond.

Authors:  Karen K Ballen; Eliane Gluckman; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

10.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615
View more
  1 in total

Review 1.  Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.

Authors:  Faroogh Marofi; Heshu Sulaiman Rahman; Zaid Mahdi Jaber Al-Obaidi; Abduladheem Turki Jalil; Walid Kamal Abdelbasset; Wanich Suksatan; Aleksei Evgenievich Dorofeev; Navid Shomali; Max Stanley Chartrand; Yashwant Pathak; Ali Hassanzadeh; Behzad Baradaran; Majid Ahmadi; Hossein Saeedi; Safa Tahmasebi; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-08-20       Impact factor: 6.832
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.